BlackRock Group LTD cut its stake in shares of Phibro Animal Health Corporation (NASDAQ:PAHC) by 1.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 303,132 shares of the company’s stock after selling 2,975 shares during the period. BlackRock Group LTD owned approximately 0.77% of Phibro Animal Health Corporation worth $8,240,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in PAHC. Rhumbline Advisers raised its position in shares of Phibro Animal Health Corporation by 6.7% in the third quarter. Rhumbline Advisers now owns 23,674 shares of the company’s stock valued at $643,000 after buying an additional 1,482 shares in the last quarter. Teachers Advisors LLC raised its position in shares of Phibro Animal Health Corporation by 0.4% in the third quarter. Teachers Advisors LLC now owns 286,145 shares of the company’s stock valued at $7,777,000 after buying an additional 1,160 shares in the last quarter. New York State Common Retirement Fund raised its position in shares of Phibro Animal Health Corporation by 22.4% in the third quarter. New York State Common Retirement Fund now owns 21,300 shares of the company’s stock valued at $579,000 after buying an additional 3,900 shares in the last quarter. BlackRock Fund Advisors raised its position in shares of Phibro Animal Health Corporation by 2.8% in the third quarter. BlackRock Fund Advisors now owns 1,509,360 shares of the company’s stock valued at $41,024,000 after buying an additional 41,291 shares in the last quarter. Finally, BlackRock Advisors LLC raised its position in shares of Phibro Animal Health Corporation by 29.3% in the third quarter. BlackRock Advisors LLC now owns 683,795 shares of the company’s stock valued at $18,586,000 after buying an additional 154,944 shares in the last quarter. Institutional investors and hedge funds own 47.24% of the company’s stock.

Institutional Ownership by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) traded up 2.33% during midday trading on Friday, reaching $28.60. 1,393 shares of the company’s stock traded hands. Phibro Animal Health Corporation has a 52-week low of $16.80 and a 52-week high of $35.69. The stock has a market cap of $1.13 billion, a P/E ratio of 14.97 and a beta of 1.39. The stock has a 50-day moving average price of $28.29 and a 200-day moving average price of $24.73.

Phibro Animal Health Corporation (NASDAQ:PAHC) last announced its quarterly earnings results on Wednesday, November 9th. The company reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.02. The company had revenue of $188 million for the quarter, compared to analyst estimates of $188.85 million. Phibro Animal Health Corporation had a net margin of 10.13% and a return on equity of 75.49%. The firm’s revenue was up .5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.44 EPS. Analysts forecast that Phibro Animal Health Corporation will post $1.41 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Wednesday, December 21st. Investors of record on Wednesday, November 30th were issued a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a dividend yield of 1.43%. The ex-dividend date of this dividend was Monday, November 28th. Phibro Animal Health Corporation’s dividend payout ratio (DPR) is presently 21.05%.

COPYRIGHT VIOLATION WARNING: This report was first published by Daily Political and is the sole property of of Daily Political. If you are reading this report on another domain, it was stolen and republished in violation of U.S. and international copyright & trademark laws. The correct version of this report can be viewed at http://www.dailypolitical.com/2017/01/13/blackrock-group-ltd-cuts-stake-in-phibro-animal-health-corporation-pahc.html.

Several brokerages recently weighed in on PAHC. Piper Jaffray Companies began coverage on shares of Phibro Animal Health Corporation in a report on Thursday, December 15th. They issued an “overweight” rating and a $32.00 price objective on the stock. Macquarie lowered shares of Phibro Animal Health Corporation from a “neutral” rating to an “underperform” rating and set a $21.00 price objective on the stock. in a report on Friday, November 11th. Gabelli lowered shares of Phibro Animal Health Corporation from a “buy” rating to a “hold” rating in a report on Thursday, November 10th. Zacks Investment Research upgraded shares of Phibro Animal Health Corporation from a “strong sell” rating to a “hold” rating in a report on Wednesday, November 2nd. Finally, TheStreet upgraded shares of Phibro Animal Health Corporation from a “hold” rating to a “buy” rating in a report on Friday, September 30th. Three equities research analysts have rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $27.67.

In related news, SVP Thomas G. Dagger sold 1,700 shares of Phibro Animal Health Corporation stock in a transaction that occurred on Tuesday, December 20th. The shares were sold at an average price of $30.03, for a total transaction of $51,051.00. Following the sale, the senior vice president now directly owns 200 shares of the company’s stock, valued at approximately $6,006. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Larry Lee Miller sold 1,540 shares of Phibro Animal Health Corporation stock in a transaction that occurred on Tuesday, December 20th. The shares were sold at an average price of $30.04, for a total transaction of $46,261.60. Following the sale, the chief operating officer now directly owns 252 shares in the company, valued at $7,570.08. The disclosure for this sale can be found here. Corporate insiders own 48.09% of the company’s stock.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation is an animal health and mineral nutrition company. The Company is engaged in developing, manufacturing and marketing products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. The Company operates through three segments: Animal Health, Mineral Nutrition and Performance Products.

5 Day Chart for NASDAQ:PAHC

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corporation (NASDAQ:PAHC).

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.